Benzinga's Top Initiations By: Benzinga via Benzinga August 01, 2014 at 09:22 AM EDT Analysts at Roth Capital initiated coverage on Alcobra Pharma (NASDAQ: ADHD) with a Buy rating. The target price for Alcobra Pharma is ... Read More >> Related Stocks: Arcturus Therapeutics Holdings Inc Sangamo Therapeutics The Finish Line, Inc. - Class A Common Stock